Engineers Gate Manager LP Sarepta Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

$8.12 Billion
Q3 2025

A detailed history of Engineers Gate Manager LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 153,257 shares of SRPT stock, worth $2.88 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

153,257

Previous 142,827 7.3%

Holding current value

$2.88 Million

Previous $2.44 Million 20.93%

% of portfolio

0.04%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$11.93 - $21.97 $124,429 - $229,147	10,430 Added 7.3%	153,257 $2.95 Million
Q2 2025 Aug 14, 2025	BUY	$17.1 - $63.66 $1.15 Million - $4.29 Million	67,430 Added 89.43%	142,827 $2.44 Million
Q1 2025 May 15, 2025	BUY	$63.82 - $127.89 $4.81 Million - $9.64 Million	75,397 New	75,397 $4.81 Million
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $680,706 - $858,206	5,475 New	5,475 $683,000
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $1.39 Million - $2.1 Million	-14,806 Reduced 54.51%	12,354 $1.6 Million

Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $1.83 Million - $3.39 Million	27,160 New	27,160 $2.62 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $1.7 Million - $2.51 Million	-15,998 Reduced 52.29%	14,599 $1.67 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $3.11 Million - $4.13 Million	26,465 Added 640.49%	30,597 $4.22 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $416,753 - $545,961	4,132 New	4,132 $535,000
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $198,225 - $279,647	-3,162 Reduced 32.42%	6,590 $494,000
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $615,838 - $881,775	9,752 New	9,752 $762,000
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $1.46 Million - $2.04 Million	-22,075 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $671,251 - $839,306	9,675 Added 78.02%	22,075 $1.72 Million
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $895,900 - $2.09 Million	12,400 New	12,400 $924,000
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $1.01 Million - $1.44 Million	-8,030 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $141,230 - $191,469	1,111 Added 16.06%	8,030 $1.13 Million
Q2 2020 Aug 17, 2020	BUY	$93.0 - $171.7 $296,205 - $546,864	3,185 Added 85.3%	6,919 $1.11 Million
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $307,606 - $491,543	3,734 New	3,734 $365,000

Others Institutions Holding SRPT

# of Institutions

408

Shares Held

83.7M

Call Options Held

5.27M

Put Options Held

5.94M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Sarepta Therapeutics, Inc. Transaction History